Copyright Reports & Markets. All rights reserved.

Global Oncolytic Virus Market by Manufacturers, Regions, Type and Application, Forecast to 2023

Request for Sample of this report
Buy now

Table of Contents

    Global Oncolytic Virus Market by Manufacturers, Regions, Type and Application, Forecast to 2023

      1 Report Overview

      • 1.1 Definition and Specification
      • 1.2 Report Overview
        • 1.2.1 Manufacturers Overview
        • 1.2.2 Regions Overview
        • 1.2.3 Type Overview
        • 1.2.4 Application Overview
      • 1.3 Industrial Chain
        • 1.3.1 Oncolytic Virus Overall Industrial Chain
        • 1.3.2 Upstream
        • 1.3.3 Downstream
      • 1.4 Industry Situation
        • 1.4.1 Industrial Policy
        • 1.4.2 Product Preference
        • 1.4.3 Economic/Political Environment
      • 1.5 SWOT Analysis

      2 Product Type Market

      • 2.1 World Product Type Market Performance and Trend
        • 2.1.1 World Market Performance
        • 2.1.2 Different Type of Market Performance
      • 2.2 North America Product Type Market Performance and Trend
        • 2.2.1 North America Market Performance
        • 2.2.2 Different Type of Market Performance
      • 2.3 Europe Product Type Market Performance and Trend
        • 2.3.1 Europe Market Performance
        • 2.3.2 Different Type of Market Performance
      • 2.4 Asia-Pacific Product Type Market Performance and Trend
        • 2.4.1 Asia-Pacific Market Performance
        • 2.4.2 Different Type of Market Performance
      • 2.5 South America Product Type Market Performance and Trend
        • 2.5.1 South America Market Performance
        • 2.5.2 Different Type of Market Performance
      • 2.6 Middle East and Africa Product Type Market Performance and Trend
        • 2.6.1 Middle East and Africa Market Performance
        • 2.6.2 Different Type of Market Performance

      3 Product Application Market

      • 3.1 World Product Application Market Performance and Trend
        • 3.1.1 World Market Performance
        • 3.1.2 Different Applications of Market Trend
      • 3.2 North America Product Application Market Performance and Trend
        • 3.2.1 North America Market Performance
        • 3.2.2 Different Applications of Market Trend
      • 3.3 Europe Product Application Market Performance and Trend
        • 3.3.1 Europe Market Performance
        • 3.3.2 Different Applications of Market Trend
      • 3.4 Asia-Pacific Product Application Market Performance and Trend
        • 3.4.1 Asia-Pacific Market Performance
        • 3.4.2 Different Applications of Market Trend
      • 3.5 South America Product Application Market Performance and Trend
        • 3.5.1 South America Market Performance
        • 3.5.2 Different Applications of Market Trend
      • 3.6 Middle East and Africa Product Application Market Performance and Trend
        • 3.6.1 Middle East and Africa Market Performance
        • 3.6.2 Different Applications of Market Trend

      4 Manufacturers Profiles/Analysis

      • 4.1 Merck
        • 4.1.1 Merck Profiles
        • 4.1.2 Merck Product Information
        • 4.1.3 Merck Oncolytic Virus Business Performance
        • 4.1.4 Merck Oncolytic Virus Business Development and Market Status
      • 4.2 Otsuka Pharmaceutical Co
        • 4.2.1 Otsuka Pharmaceutical Co Profiles
        • 4.2.2 Otsuka Pharmaceutical Co Product Information
        • 4.2.3 Otsuka Pharmaceutical Co Oncolytic Virus Business Performance
        • 4.2.4 Otsuka Pharmaceutical Co Oncolytic Virus Business Development and Market Status
      • 4.3 Pfizer
        • 4.3.1 Pfizer Profiles
        • 4.3.2 Pfizer Product Information
        • 4.3.3 Pfizer Oncolytic Virus Business Performance
        • 4.3.4 Pfizer Oncolytic Virus Business Development and Market Status
      • 4.4 Roche
        • 4.4.1 Roche Profiles
        • 4.4.2 Roche Product Information
        • 4.4.3 Roche Oncolytic Virus Business Performance
        • 4.4.4 Roche Oncolytic Virus Business Development and Market Status
      • 4.5 Cold Genesys
        • 4.5.1 Cold Genesys Profiles
        • 4.5.2 Cold Genesys Product Information
        • 4.5.3 Cold Genesys Oncolytic Virus Business Performance
        • 4.5.4 Cold Genesys Oncolytic Virus Business Development and Market Status
      • 4.6 Genelux
        • 4.6.1 Genelux Profiles
        • 4.6.2 Genelux Product Information
        • 4.6.3 Genelux Oncolytic Virus Business Performance
        • 4.6.4 Genelux Oncolytic Virus Business Development and Market Status
      • 4.7 Latima
        • 4.7.1 Latima Profiles
        • 4.7.2 Latima Product Information
        • 4.7.3 Latima Oncolytic Virus Business Performance
        • 4.7.4 Latima Oncolytic Virus Business Development and Market Status
      • 4.8 Neotropix
        • 4.8.1 Neotropix Profiles
        • 4.8.2 Neotropix Product Information
        • 4.8.3 Neotropix Oncolytic Virus Business Performance
        • 4.8.4 Neotropix Oncolytic Virus Business Development and Market Status
      • 4.9 Shanghai Sunway Biotech
        • 4.9.1 Shanghai Sunway Biotech Profiles
        • 4.9.2 Shanghai Sunway Biotech Product Information
        • 4.9.3 Shanghai Sunway Biotech Oncolytic Virus Business Performance
        • 4.9.4 Shanghai Sunway Biotech Oncolytic Virus Business Development and Market Status
      • 4.10 SillaJen
        • 4.10.1 SillaJen Profiles
        • 4.10.2 SillaJen Product Information
        • 4.10.3 SillaJen Oncolytic Virus Business Performance
        • 4.10.4 SillaJen Oncolytic Virus Business Development and Market Status
      • 4.11 Takara Bio
      • 4.12 Theravir

      5 Market Performance for Manufacturers

      • 5.1 Global Oncolytic Virus Sales (K Units) and Market Share by Manufacturers 2013-2018
      • 5.2 Global Oncolytic Virus Revenue (M USD) and Market Share by Manufacturers 2013-2018
      • 5.3 Global Oncolytic Virus Price (USD/Unit) of Manufacturers 2013-2018
      • 5.4 Global Oncolytic Virus Gross Margin of Manufacturers 2013-2018
      • 5.5 Market Concentration

      6 Regions Market Performance for Manufacturers

      • 6.1 North America Market Performance for Manufacturers
        • 6.1.1 North America Oncolytic Virus Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.1.2 North America Oncolytic Virus Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.1.3 North America Oncolytic Virus Price (USD/Unit) of Manufacturers 2013-2018
        • 6.1.4 North America Oncolytic Virus Gross Margin of Manufacturers 2013-2018
        • 6.1.5 Market Concentration
      • 6.2 Europe Market Performance for Manufacturers
        • 6.2.1 Europe Oncolytic Virus Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.2.2 Europe Oncolytic Virus Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.2.3 Europe Oncolytic Virus Price (USD/Unit) of Manufacturers 2013-2018
        • 6.2.4 Europe Oncolytic Virus Gross Margin of Manufacturers 2013-2018
        • 6.2.5 Market Concentration
      • 6.3 Asia-Pacific Market Performance for Manufacturers
        • 6.3.1 Asia-Pacific Oncolytic Virus Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.3.2 Asia-Pacific Oncolytic Virus Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.3.3 Asia-Pacific Oncolytic Virus Price (USD/Unit) of Manufacturers 2013-2018
        • 6.3.4 Asia-Pacific Oncolytic Virus Gross Margin of Manufacturers 2013-2018
        • 6.3.5 Market Concentration
      • 6.4 South America Market Performance for Manufacturers
        • 6.4.1 South America Oncolytic Virus Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.4.2 South America Oncolytic Virus Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.4.3 South America Oncolytic Virus Price (USD/Unit) of Manufacturers 2013-2018
        • 6.4.4 South America Oncolytic Virus Gross Margin of Manufacturers 2013-2018
        • 6.4.5 Market Concentration
      • 6.5 Middle East and Africa Market Performance for Manufacturers
        • 6.5.1 Middle East and Africa Oncolytic Virus Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.5.2 Middle East and Africa Oncolytic Virus Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.5.3 Middle East and Africa Oncolytic Virus Price (USD/Unit) of Manufacturers 2013-2018
        • 6.5.4 Middle East and Africa Oncolytic Virus Gross Margin of Manufacturers 2013-2018
        • 6.5.5 Market Concentration

      7 World Market Performance Point

      • 7.1 World Oncolytic Virus Sales (K Units) and Share by Regions and Countries 2013-2018
        • 7.1.1 World Oncolytic Virus Sales (K Units) and Share by Regions 2013-2018
        • 7.1.2 Regional Sales (K Units) and Share by Countries 2013-2018
          • 7.1.2.1 Asia-Pacific Oncolytic Virus Sales (K Units) and Share by Countries 2013-2018
          • 7.1.2.2 North America Oncolytic Virus Sales (K Units) and Share by Countries 2013-2018
          • 7.1.2.3 Europe Oncolytic Virus Sales (K Units) and Share by Countries 2013-2018
          • 7.1.2.4 South America Oncolytic Virus Sales (K Units) and Share by Countries 2013-2018
          • 7.1.2.5 Middle East and Africa Oncolytic Virus Sales (K Units) and Share by Countries 2013-2018
      • 7.2 World Revenue (M USD) and Share by Regions and Countries 2013-2018
        • 7.2.1 World Revenue (M USD) and Share by Regions 2013-2018
        • 7.2.2 Regional Revenue (M USD) and Share by Countries 2013-2018
          • 7.2.2.1 Asia-Pacific Oncolytic Virus Revenue (M USD) and Share by Countries 2013-2018
          • 7.2.2.2 North America Oncolytic Virus Revenue (M USD) and Share by Countries 2013-2018
          • 7.2.2.3 Europe Oncolytic Virus Revenue (M USD) and Share by Countries 2013-2018
          • 7.2.2.4 South America Oncolytic Virus Revenue (M USD) and Share by Countries 2013-2018
          • 7.2.2.5 Middle East and Africa Oncolytic Virus Revenue (M USD) and Share by Countries 2013-2018
      • 7.3 World Price (USD/Unit) by Regions and Countries 2013-2018
        • 7.3.1 World Price (USD/Unit) by Regions 2013-2018
        • 7.3.2 Regional Price (USD/Unit) by Countries 2013-2018
          • 7.3.2.1 Asia-Pacific Oncolytic Virus Price (USD/Unit) by Countries 2013-2018
          • 7.3.2.2 North America Oncolytic Virus Price (USD/Unit) by Countries 2013-2018
          • 7.3.2.3 Europe Oncolytic Virus Price (USD/Unit) by Countries 2013-2018
          • 7.3.2.4 South America Oncolytic Virus Price (USD/Unit) by Countries 2013-2018
          • 7.3.2.5 Middle East and Africa Oncolytic Virus Price (USD/Unit) by Countries 2013-2018
      • 7.4 World Gross Margin by Regions and Countries 2013-2018
        • 7.4.1 World Gross Margin by Regions 2013-2018
        • 7.4.2 Regional Gross Margin and Share by Countries 2013-2018
          • 7.4.2.1 Asia-Pacific Oncolytic Virus Gross Margin and Share by Countries 2013-2018
          • 7.4.2.2 North America Oncolytic Virus Gross Margin and Share by Countries 2013-2018
          • 7.4.2.3 Europe Oncolytic Virus Gross Margin and Share by Countries 2013-2018
          • 7.4.2.4 South America Oncolytic Virus Gross Margin and Share by Countries 2013-2018
          • 7.4.2.5 Middle East and Africa Oncolytic Virus Gross Margin and Share by Countries 2013-2018

        8 Development Trend for Regions and Countries (Sales Point)

        • 8.1 World Oncolytic Virus Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
        • 8.2 Asia-Pacific Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.2.1 China Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.2.2 Japan Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.2.3 Korea Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.2.4 India Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.2.5 Southeast Asia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
        • 8.3 North America Oncolytic Virus Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.3.1 United States Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.3.2 Canada Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.3.3 Mexico Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
        • 8.4 Europe Oncolytic Virus Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.4.1 Germany Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.4.2 UK Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.4.3 France Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.4.4 Russia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.4.5 Italy Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
        • 8.5 South America Oncolytic Virus Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.5.1 Brazil Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.5.2 Argentina Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.5.3 Columbia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
        • 8.6 Middle East and Africa Oncolytic Virus Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.6.1 Saudi Arabia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.6.2 UAE Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.6.3 Egypt Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.6.4 Nigeria Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.6.5 South Africa Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018

        9 Upstream Source, Technology and Cost

        • 9.1 Upstream Source
        • 9.2 Technology
        • 9.3 Cost

        10 Channel Analysis

        • 10.1 Market Channel
        • 10.2 Distributors

        11 Consumer Analysis

        • 11.1 Pharmaceutical Industry
        • 11.2 Health Care Industry
        • 11.3 Commerical Industry

        12 Market Forecast 2019-2024

        • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
          • 12.1.1 Global Oncolytic Virus Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
          • 12.1.2 Global Oncolytic Virus Sales (K Units) and Growth Rate 2019-2024
          • 12.1.3 Asia-Pacific Oncolytic Virus Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
          • 12.1.4 Asia-Pacific Oncolytic Virus Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
          • 12.1.5 Europe Oncolytic Virus Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
          • 12.1.6 South America Oncolytic Virus Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
          • 12.1.7 Middle East and Africa Oncolytic Virus Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 12.2 Sales (K Units), Revenue (M USD) by Types 2019-2024
          • 12.2.1 Overall Market Performance
          • 12.2.2 HSV-based Oncolytic Viruses Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
          • 12.2.3 Adenoviruses-based Oncolytic Viruses Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
          • 12.2.4 Vaccinia Virus-based Oncolytic Viruses Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
          • 12.2.5 Vesicular Stomatitis Virus-based Oncolytic Viruses Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 12.3 Sales by Application 2019-2024
          • 12.3.1 Overall Market Performance
          • 12.3.2 Pharmaceutical Sales and and Growth Rate 2019-2024
          • 12.3.3 Health Care Sales and and Growth Rate 2019-2024
          • 12.3.4 Commerical Sales and and Growth Rate 2019-2024
        • 12.4 Price (USD/Unit) and Gross Profit
          • 12.4.1 Global Oncolytic Virus Price (USD/Unit) Trend 2019-2024
          • 12.4.2 Global Oncolytic Virus Gross Profit Trend 2019-2024

        13 Conclusion

      Geographically, this report is segmented into several key Regions, with production, consumption, revenue (M USD), market share and growth rate of Oncolytic Virus in these regions, from 2012 to 2023 (forecast), covering
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Columbia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
      Global Oncolytic Virus market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
      Merck
      Otsuka Pharmaceutical Co
      Pfizer
      Roche
      Cold Genesys
      Genelux
      Latima
      Neotropix
      Shanghai Sunway Biotech
      SillaJen
      Takara Bio
      Theravir
      On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
      HSV-based Oncolytic Viruses
      Adenoviruses-based Oncolytic Viruses
      Vaccinia Virus-based Oncolytic Viruses
      Vesicular Stomatitis Virus-based Oncolytic Viruses
      Newcastle Disease Virus-based Oncolytic Viruses
      On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Oncolytic Virus for each application, including
      Pharmaceutical
      Health Care
      Commerical

      If you have any special requirements, please let us know and we will offer you the report as you want.

      Buy now